De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice Alex Arenas; María José Moreta; Ingrid Ordás; Agnès Fernández-Clotet; Berta Caballol; Marta Gallego; Alejandro Vara; Rebeca Barastegui; Angel Giner; Cristina Prieto; Maria Carme Masamunt; Roberto Candia; Elena Ricart;

Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease Lidia Serrano Díaz; Carles Iniesta Navalón; Rosa Gómez Espín; Isabel Nicolás de Prado; Lorena Rentero Redondo;

Infliximab serum concentrations in luminal Crohn's disease and its relationship with disease activity: A multicentric cross-sectional study Rodrigo Bremer Nones; Eron Fabio Miranda; Gustavo de Nardi Marçal; Fernanda da Silva Barbosa Baraúna; Marcela Rocha Loures; Paula Cenira Senger; Daniela Oliveira Magro; Paulo Gustavo Kotze;